APYI — Arypsa Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual income statement for Arypsa, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2004 August 31st | 2005 December 31st | 2006 December 31st | 2007 December 31st | 2008 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10KSB | 10KSB | 10KSB | 10KSB | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 7.66 | 7.21 | 12.7 | 10.3 | 8.53 |
Cost of Revenue | |||||
Gross Profit | 4.15 | 3.51 | 5.88 | 4.87 | 3.92 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 7.38 | 8.89 | 16 | 14.5 | 13.2 |
Operating Profit | 0.279 | -1.68 | -3.34 | -4.2 | -4.7 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 0.28 | -1.7 | -3.56 | -4.21 | -5.18 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.162 | -2.5 | -3.57 | -4.22 | -5.19 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.162 | -2.5 | -3.57 | -4.22 | -5.19 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 0.162 | -2.5 | -3.57 | -5 | -5.19 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.72 | -62.6 | -36.4 | -44.6 | -39.1 |
Dividends per Share |